Young adults’ beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping.
Experimental and Clinical Psychopharmacology · 2023-04 · 31 (2) · 455-463
DOI: 10.1037/pha0000595 ↗At a glance
Journal article in Experimental and Clinical Psychopharmacology, 2023-04. Written by Dae-Hee Han and 9 co-authors. Institution: Institute for Addiction Science, University of Southern California. Major MEDLINE topics: Vaping, Electronic Nicotine Delivery Systems, Smoking Cessation, Tobacco Products. Cited 25 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: NIDA NIH HHS, NHLBI NIH HHS, NCI NIH HHS.
Abstract (original language)
Modern oral nicotine products (ONPs; nontherapeutic nicotine pouches, gums, lozenges, and gummies) may be perceived in ways that could promote uptake in nonvapers, dual use with e-cigarettes, or use to quit vaping. In this cross-sectional digital remote survey of 1,460 respondents aged 21-24 from Southern California, we examined beliefs about ONPs among past-30-day e-cigarette nonusers, users unmotivated to quit vaping, and users motivated to quit vaping. Positive beliefs about ONPs were reported by 31.8% of the overall sample and higher in past-30-day e-cigarette users (with or without quit motivation) than nonusers. Perceiving ONPs to be easy to conceal, convenient, and able to be used where vaping/smoking is not allowed were the most common types of beliefs reported. Among e-cigarette users with quit motivation (n = 142), interest in using ONPs to quit/reduce vaping (44.4%) was higher than interest in using medicinal nicotine gum/lozenges (23.4%), nicotine patch (17.6%), or prescription medications (16.6%). Interest in using ONPs to reduce/quit vaping (vs. no interest) was greater among participants who reported vaping ≥ 20 (vs. < 10) days in the past month, vaping ≥ 10 (vs. < 10) times per day, low/moderate (vs. high) quit vaping self-efficacy, and low/moderate (vs. high) desire to quit vaping. These findings suggest that: (a) appreciable subsets of the young adult population may hold positive beliefs about ONPs that could promote ONP uptake, particularly e-cigarette users and (b) some young adult e-cigarette users may be interested in using ONPs to reduce/quit vaping, particularly frequent vapers with relatively lower self-efficacy and desire to quit vaping. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Institute for Addiction Science, University of Southern California.
ORCID profiles: Dae-Hee Han, Junhan Cho
Funding
- NIDA NIH HHS
- NHLBI NIH HHS
- NCI NIH HHS
- National Cancer Institute
- Food and Drug Administration
- National Institute on Drug Abuse
- National Heart, Lung, and Blood Institute
Cite
APA
Han, D. H., Cho, J., Harlow, A. F., Tackett, A. P., Vogel, E. A., Wong, M., Barrington-Trimis, J. L., Lerman, C., Unger, J. B., & Leventhal, A. M. (2023). Young adults’ beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping. Experimental and Clinical Psychopharmacology, 31(2), 455-463. https://doi.org/10.1037/pha0000595
Vancouver
Han DH, Cho J, Harlow AF, Tackett AP, Vogel EA, Wong M, et al. Young adults’ beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping. Experimental and Clinical Psychopharmacology. 2023;31(2):455-463. doi:10.1037/pha0000595
BibTeX
@article{Han2023,
author = {Han, Dae-Hee and Cho, Junhan and Harlow, Alyssa F and Tackett, Alayna P and Vogel, Erin A and Wong, Melissa and Barrington-Trimis, Jessica L and Lerman, Caryn and Unger, Jennifer B and Leventhal, Adam M},
title = {Young adults’ beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping},
journal = {Experimental and Clinical Psychopharmacology},
year = {2023},
volume = {31},
number = {2},
pages = {455--463},
doi = {10.1037/pha0000595}
}
EUVIMED